Bills Search Results

Search all bills

Keyword(s)
Status
Current Bills
Previous Bills
Type

TOTAL RESULTS: 394

  • Date
    31 Aug 2016 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Health 
    Summary
    Introduced with the National Cancer Screening Register (Consequential and Transitional Provisions) Bill 2016, the bill: establishes the National Cancer Screening Register, a national electronic infrastructure for the collection, storage, analysis and reporting of cancer screen program data for the National Cervical Screening Program and the National Bowel Cancer Screening Program; authorises the collection, use and disclosure of information for the purposes of the register; creates an offence for the unauthorised disclosure of information; and mandates reporting of screening information to the register. 

    Bill | Explanatory Memorandum

  • Date
    31 Aug 2016 
    Chamber
    House of Representatives 
    Status
    Not Proceeding 
    Portfolio
    Social Services 
    Summary
    Establishes the National Disability Insurance Scheme Savings Fund Special Account to assist the Commonwealth to meet its funding obligations in relation to the National Disability Insurance Scheme. 

    Bill | Explanatory Memorandum

  • Date
    05 May 2016 
    Chamber
    House of Representatives 
    Status
    Not Proceeding 
    Portfolio
    Health 
    Summary
    Introduced with the National Cancer Screening Register Bill 2016, the bill amends the
    Australian Immunisation Register Act 2015
    ,
    Australian Institute of Health and Welfare Act 1987
    and
    Health Insurance Act 1973
    to authorise the disclosure of specified information for inclusion in the National Cancer Screening Register. Also authorises the transfer of state and territory cervical screening data to the register. 

    Bill | Explanatory Memorandum

  • Date
    05 May 2016 
    Chamber
    House of Representatives 
    Status
    Not Proceeding 
    Portfolio
    Health 
    Summary
    Introduced with the National Cancer Screening Register (Consequential and Transitional Provisions) Bill 2016, the bill: establishes the National Cancer Screening Register, a national electronic infrastructure for the collection, storage, analysis and reporting of cancer screen program data for the National Cervical Screening Program and the National Bowel Cancer Screening Program; authorises the collection, use and disclosure of information for the purposes of the register; creates an offence for the unauthorised disclosure of information; and mandates reporting of screening information to the register. 

    Bill | Explanatory Memorandum

  • Date
    17 Mar 2016 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Industry, Innovation and Science 
    Summary
    Introduced with the Northern Australia Infrastructure Facility Bill 2016, the bill amends the
    Export Finance and Insurance Corporation Act 1991
    to enable the Export Finance and Insurance Corporation to: assist the Northern Australia Infrastructure Facility; assist, on agreement, the states and territories; and charge fees to the facility and the states and territories for the services it provides in performing its functions for them. 

    Bill | Explanatory Memorandum

  • Date
    17 Mar 2016 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Industry, Innovation and Science 
    Summary
    Introduced with the Northern Australia Infrastructure Facility (Consequential Amendments) Bill 2016, the bill establishes the Northern Australia Infrastructure Facility and a Board of the Facility to make investment decisions for the facility; and provides up to $5 billion in concessional finance over five years to provide financial assistance to state and territory governments to develop economic infrastructure in the Northern Territory and northern parts of Western Australia and Queensland. 

    Bill | Explanatory Memorandum

  • Date
    16 Mar 2016 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Social Services 
    Summary
    Amends the
    National Disability Insurance Scheme Act 2013
    to increase the maximum number of board members of the National Disability Insurance Scheme Launch Transition Agency to 12 members, including the Chair; and clarify the quorum arrangements for board meetings. 

    Bill | Explanatory Memorandum

  • Date
    16 Mar 2016 
    Chamber
    House of Representatives 
    Status
    Not Proceeding 
    Portfolio
    Social Services 
    Summary
    Establishes the National Disability Insurance Scheme Savings Fund Special Account to assist the Commonwealth to meet its funding obligations in relation to the National Disability Insurance Scheme. 

    Bill | Explanatory Memorandum

  • Date
    10 Feb 2016 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Health 
    Summary
    Amends the
    Narcotic Drugs Act 1967
    to: give effect to certain of Australia’s obligations under the Single Convention on Narcotic Drugs, 1961 (the Single Convention); establish licensing and permit schemes for the cultivation and production of cannabis and cannabis resin for medicinal and scientific purposes, and for the manufacture of narcotic drugs covered by the Single Convention; provide for monitoring, inspection and enforcement powers for authorised inspectors and for the secretary to give directions to licence holders and former licence holders; and enable the secretary to authorise a state or territory government agency to undertake cultivation and production of cannabis and manufacture of medicinal cannabis products; and the
    Therapeutic Goods Act 1989
    to make a consequential amendment. 

    Bill | Explanatory Memorandum

  • Date
    27 May 2015 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Health 
    Summary
    Amends the
    National Health Act 1953
    to implement the Pharmaceutical Benefits Scheme (PBS) Access and Sustainability package by: applying a one-off five per cent statutory price reduction for single brand medicines; changing price disclosure arrangements for multiple-brand medicines; applying flow-on price disclosure reductions from component drugs to multiple-brand combination medicines; changing membership arrangements for the Pharmaceutical Benefits Advisory Committee; enabling approved pharmacists to discount patient co-payments by a maximum of $1 for each PBS supply on a prescription; extending safety net early supply rules; and extending the pharmacy location rules and the role of the Australian Community Pharmacy Authority to 30 June 2020. Also makes technical amendments. 

    Bill | Explanatory Memorandum